|
Supreme Court Sides With Generic Maker in Closely Watched Patent Case
The Supreme Court has unanimously ruled that generic-drug maker Caraco Pharmaceuticals can challenge Novo Nordisk’s “overbroad” patent listing for diabetes drug Prandin, reversing and remanding a lower court’s decision that critics called an existential threat to the generic industry.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives